Jean-Marc Bellemin - Chief Financial Officer at Iovance Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
IOVA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jean-Marc Bellemin since 4/23/2024

Holdings reported by Jean-Marc Bellemin for Iovance Biotherapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 93.8K $379K $4.04 Mar 5, 2025 Direct Common stock
Common Stock 56.2K $227K $4.04 Mar 3, 2025 Direct

Transactions reported by Jean-Marc Bellemin for Iovance Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.